192 related articles for article (PubMed ID: 1689463)
1. Retinoblastoma in transgenic mice.
Windle JJ; Albert DM; O'Brien JM; Marcus DM; Disteche CM; Bernards R; Mellon PL
Nature; 1990 Feb; 343(6259):665-9. PubMed ID: 1689463
[TBL] [Abstract][Full Text] [Related]
2. Trilateral retinoblastoma in transgenic mice.
O'Brien JM; Marcus DM; Niffenegger AS; Bernards R; Carpenter JL; Windle JJ; Mellon P; Albert DM
Trans Am Ophthalmol Soc; 1989; 87():301-22; discussion 322-6. PubMed ID: 2576479
[No Abstract] [Full Text] [Related]
3. Transgenic models of retinoblastoma: what they tell us about its cause and treatment.
Albert DM; Griep AE; Lambert PF; Howes KA; Windle JJ; Lasudry JG
Trans Am Ophthalmol Soc; 1994; 92():385-400; discussion 400-1. PubMed ID: 7886874
[No Abstract] [Full Text] [Related]
4. Expression level of the retinoblastoma susceptibility gene is elevated in simian virus 40-transformed cells.
Moritsuka T; Kobori O; Morioka Y; Watanabe S; Yamaguchi N; Sugano S
Oncogene Res; 1989; 5(2):155-9. PubMed ID: 2558336
[TBL] [Abstract][Full Text] [Related]
5. Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen.
Marcus DM; Lasudry JG; Carpenter JL; Windle J; Howes KA; al-Ubaidi MR; Baehr W; Overbeek PA; Font RL; Albert DM
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):392-6. PubMed ID: 8603844
[TBL] [Abstract][Full Text] [Related]
6. Local carboplatin therapy in transgenic murine retinoblastoma.
Harbour JW; Murray TG; Hamasaki D; Cicciarelli N; Hernández E; Smith B; Windle J; O'Brien JM
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1892-8. PubMed ID: 8759359
[TBL] [Abstract][Full Text] [Related]
7. Primitive neuroectodermal tumor of the midbrain in a murine model of retinoblastoma.
Marcus DM; Carpenter JL; O'Brien JM; Kivela T; Brauner E; Tarkkanen A; Virtanen I; Albert DM
Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):293-301. PubMed ID: 1993580
[TBL] [Abstract][Full Text] [Related]
8. Photoreceptor cell tumors in transgenic mice.
Howes KA; Lasudry JG; Albert DM; Windle JJ
Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):342-51. PubMed ID: 8112979
[TBL] [Abstract][Full Text] [Related]
9. Multiple genetic loci modify risk for retinoblastoma in transgenic mice.
Griep AE; Krawcek J; Lee D; Liem A; Albert DM; Carabeo R; Drinkwater N; McCall M; Sattler C; Lasudry JG; Lambert PF
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2723-32. PubMed ID: 9856783
[TBL] [Abstract][Full Text] [Related]
10. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T.
Ludlow JW; Shon J; Pipas JM; Livingston DM; DeCaprio JA
Cell; 1990 Feb; 60(3):387-96. PubMed ID: 2154332
[TBL] [Abstract][Full Text] [Related]
11. A transgenic mouse model for trilateral retinoblastoma.
O'Brien JM; Marcus DM; Bernards R; Carpenter JL; Windle JJ; Mellon P; Albert DM
Arch Ophthalmol; 1990 Aug; 108(8):1145-51. PubMed ID: 1696469
[TBL] [Abstract][Full Text] [Related]
12. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
Dyson N; Howley PM; Münger K; Harlow E
Science; 1989 Feb; 243(4893):934-7. PubMed ID: 2537532
[TBL] [Abstract][Full Text] [Related]
13. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma.
Murray TG; Roth DB; O'Brien JM; Feuer W; Cicciarelli N; Markoe AM; Hernández E; Smith BJ; Windle JJ
Arch Ophthalmol; 1996 Nov; 114(11):1385-9. PubMed ID: 8906029
[TBL] [Abstract][Full Text] [Related]
14. Expression of the RB gene under the control of MuLV-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblastoma cells in immunodefective mice.
Sumegi J; Uzvolgyi E; Klein G
Cell Growth Differ; 1990 May; 1(5):247-50. PubMed ID: 1964797
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma: a model of oncogenesis.
Gallie BL; Phillips RA
Ophthalmology; 1984 Jun; 91(6):666-72. PubMed ID: 6462624
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma.
Murray TG; O'Brien JM; Steeves RA; Smith BJ; Albert DM; Cicciarelli N; Markoe AM; Tompkins DT; Windle JJ
Arch Ophthalmol; 1996 Nov; 114(11):1376-81. PubMed ID: 8906028
[TBL] [Abstract][Full Text] [Related]
17. Progressive and regressive fate of lens tumors correlates with subtle differences in transgene expression in gamma F-crystallin-SV40 T antigen transgenic mice.
Bryce DM; Liu Q; Khoo W; Tsui LC; Breitman ML
Oncogene; 1993 Jun; 8(6):1611-20. PubMed ID: 8389033
[TBL] [Abstract][Full Text] [Related]
18. The molecular genetics of retinoblastoma.
Goodrich DW; Lee WH
Cancer Surv; 1990; 9(3):529-54. PubMed ID: 2101724
[TBL] [Abstract][Full Text] [Related]
19. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.
DeCaprio JA; Ludlow JW; Figge J; Shew JY; Huang CM; Lee WH; Marsilio E; Paucha E; Livingston DM
Cell; 1988 Jul; 54(2):275-83. PubMed ID: 2839300
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53.
Howes KA; Ransom N; Papermaster DS; Lasudry JG; Albert DM; Windle JJ
Genes Dev; 1994 Jun; 8(11):1300-10. PubMed ID: 7986270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
